Document is current
Any future updates will be listed below
-
Authors
Shah, Vrutant V. http://orcid.org/0000-0001-5342-6513
Duncan, Aundrietta D. http://orcid.org/0000-0002-1094-4844
Jiang, Shiming
Stratton, Sabrina A. http://orcid.org/0000-0002-5408-8242
Allton, Kendra L. http://orcid.org/0000-0002-4204-0807
Yam, Clinton
Jain, Abhinav
Krause, Patrick M. http://orcid.org/0000-0003-1611-9068
Lu, Yue
Cai, Shirong
Tu, Yizheng
Zhou, Xinhui
Zhang, Xiaomei http://orcid.org/0000-0003-0964-8922
Jiang, Yan
Carroll, Christopher L.
Kang, Zhijun
Liu, Bin
Shen, Jianjun
Gagea, Mihai http://orcid.org/0000-0002-2399-1375
Manu, Sebastian M.
Huo, Lei
Gilcrease, Michael
Powell, Reid T.
Guo, Lei
Stephan, Clifford
Davies, Peter J.
Parker-Thornburg, Jan http://orcid.org/0000-0002-4464-8744
Lozano, Guillermina http://orcid.org/0000-0001-8985-4886
Behringer, Richard R.
Piwnica-Worms, Helen http://orcid.org/0000-0003-4210-6738
Chang, Jeffrey T. http://orcid.org/0000-0002-4578-5636
Moulder, Stacy L.
Barton, Michelle Craig http://orcid.org/0000-0002-4042-1374
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (RO1 CA214871, RO1 CA214871)
U.S. Department of Health & Human Services | National Institutes of Health
-
License Information
Text and Data Mining valid from 2021-09-10
Version of Record valid from 2021-09-10
-
More Information
Article History
Received: 7 August 2020
Accepted: 17 August 2021
First Online: 10 September 2021
Competing interests
: S. Moulder has partial support for clinical trials from Pfizer, Genetech, Seattle Genetics, Lilly, Merck, EMDSerono, Bayer, AstraZeneca and Novartis, and no other conflict of interest. All other authors have affirmed no conflict of interest.
